Exploring polycythaemia vera with fluorescence in situ hybridization: Additional cryptic 9p is the most frequent abnormality detected

British Journal of Haematology

Volumn 119, Issue 2, 2002, Pages 558-566

  Najfeld, Vesna ^a,b   Montella, Lya ^a   Scalise, Angela ^a   Fruchtman, Steven ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Chromosomes; Cytogenetics; FISH; PV; Tetrasomy 9p; Trisomy 9p

Indexed keywords

ARTICLE; CENTROMERE; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN CELL; INTERPHASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; TRISOMY 8;

CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; MALE; POLYCYTHEMIA VERA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036439588     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03763.x     Document Type: Article

References (42)

1. Adamson, J.W., Fialkow, P.J., Murphy, S., Prrchal, J.F. & Steinman, L. (1976) Polycythemia vera: Stem cell and probable clonal origin of the disease. New England Journal of Medicine, 295, 913-916.
2. Amiel, A., Gaber, E., Manor, Y., Fejgin, M., Joseph-Lerner, N., Ravid, M. & Lisher, M. (1995) Florescence in situ hybridization for the deletion of trisomies 8 and 9 in polycythemia vera. Cancer, Genetics and Cytogenetics, 79, 153-156.
3. Berk, P.D., Goldberg, J.D., Donovan, P.B., Fruchtman, S.M., Berlin, N.I. & Wasserman, L.R. (1986) Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Seminars in Hematology, 23, 132-143.
4. Berlin, N. (1975) Diagnosis and classification of the polycythemias. Seminars in Hematology, 12, 339-351.
5. Busque, L., Mio, R., Mattioli, J., Brais, E., Blais, N., Lalonde, Y., Maraghm, M. & Gilliland, D.G. (1996) Nonrandom X inactivation patterns in normal females: Lyonization ratios vary with age. Blood, 88, 59-65.
6. Champion, K.M., Gilbert, J.G.R., Asimakopoulos, F.A., Hinshelwood, S. & Green, A.R. (1997) Clonal haematopoiesis in normal elderly woman: Implications for the myeloproliferative disorders and myelodysplastic syndromes. British Journal of Haematology, 97, 920-926.
7. Chen, Z., Notohamiprodjom, M., Guan, X.-Y., Paietta, E., Blackwell, S., Stout, K., Turner, A., Richkin, K., Trent, J.M., Lamb, A. & Sandberg, A.A. (1998) Gain of 9p in the pathogenesis of polycythemia vera. Genes, Chromosomes and Cancer, 22, 321-324.
8. Coyle, T. & Najfeld, V. (1988) Translocation (3;21) in Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis. American Journal of Hematology, 27, 56-59.
9. Den Nijs van Weert, J.I., Bevestock, G.C., Kievits, T., Haak, H.L., Havik-Bogaard, F.C.T. & Leeksma, C.H.W. (1989) der(1)t(1;9): A specific chromosome abnormality in polycythemia vera? Cytogenetic and in situ hybridization studies. Cancer Genetics Cytogenetics, 40, 121-127.
10. Dewald, G.W. & Wright, P.I. (1995) Chromosomal abnormalities in the myeloproliferative disorders. Seminars in Oncology, 22, 341-354.
11. Diez-Martin, J.L., Graham, D.L., Petitt, R.M. & Dewald, G.W. (1991) Chromosome studies in 104 patients with polycythemia vera. Mayo Clinic Proceedings, 66, 287-299.
12. Fruchtman, S., Mack, K., Kaplan, M.E., Peterson, P., Berk, P. & Wasserman, L.R. (1997) From efficacy to safety: A Polycythemia Vera Study Group report on hydroxyurea in patients with Polycythemia Vera. Seminars in Hematology, 34, 17-23.
13. Gilliland, D.G., Blanchard, K.L., Levy, J., Perrin, S. & Bunn, H.F. (1991) Clonality in myeloproliferative disorders: Analysis by means of the polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America, 88, 6848-6852.
14. Herishanu, Y., Lishner, M., Bonestein, Y., Kitay-Cohen, Y., Fejgin, M.D., Gober, E. & Amiel, A. (2001) Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients. Cancer Genetics Cytogenetics, 128, 154-157.
15. ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. F. Mitelman). S. Karger, Basel.
16. Lampert, C., Kafko, M., Scalise, A. & Najfeld, V. (1998) The value of interphase fluorescence in situ hybridization in the study of patients with lymphoproliferative disorders: Further evidence for a higher sensitivity of detecting chromosome 7 and 8 aneuploidy. Cancer Genetics Cytogenetics, 105, 193-197.
17. Lawler, S.D. (1980) Cytogenetic studies in Philadelphia chromosome negative myeloproliferative disorders. Clinics in Haematology, 9, 159-173.
18. van de Loosdrecht, A.A., deWolf, J., Th, M., Noordhoek, L. & van den Berg, E. (2001) Partial trisomy of 9p: A rare chromosomal abnormality in Polycythaemia vera. British Journal of Haematology, 112, 1806-1807.
19. Mertens, F., Johansson, B., Heim, S., Kristoffersson, U. & Mitelman, F. (1991) Karyotypic patterns in chronic myeloproliferative disorders. Report on 74 cases and review of the literature. Leukemia, 5, 214-220.
20. Moliterano, A.R., Hankins, W.E. & Spivak, J.L. (1998) Impaired expression of the thrombopoetin receptor by platelets with polycythemia vera. New England Journal of Medicine, 338, 572-580.
21. Najfeld, V., Scalise, A. & Silverman, L. (1999) Jumping translocations (JT) of the long arms of chromosome 1, at the 1q12 breakpoint, is a recurrent rearrangement in patients with the Myelodysplastic syndrome (MDS). Blood, 94, 108a.
22. Nowell, P., Jenmsen, J., Gardner, F., Murphy, S., Chaganti, R.S. & German, J. (1976) Chromosome studies in preleukemia. III. Myelofibrosis. Cancer, 38, 1873-1881.
23. Pahl, H.L. (2000) Towards a molecular understanding of polycythemia rubra vera. European Journal of Biochemistry, 267, 3395-3401.
24. Prchal, J.F. & Axelrad, A.A. (1974) Bone Marrow response in polycythemia vera. New England Journal of Medicine, 290, 1382.
25. Prchal, J.F., Adamson, J.W., Murphy, S., Steinmann, L. & Failkow, P.J. (1978) The in vitro response of normal and abnormal stem cell lines to erythropoetin. Journal of Clinical Investigation, 61, 1044-1047.
26. Raskind, W.H., Jacobson, R., Murphy, S., Adamson, J.W. & Fialkow, P.J. (1985) Evidence for the involvement of B-lymphoid cells in polycythemia vera and essential thrombocythemia. Journal of Clinical Investigation, 75, 1388-1390.
27. Raskind, W.H., Steinmann, L. & Najfeld, V. (1998) Clonal development of myeloproliferative disorders: Clues to hematopoietic differentiation and multistep pathogenesis of cancer. Leukemia, 12, 108-116.
28. Rege-Cambrin, G., Mecucci, C., Tricot, G., Michaux, J.L., Louwagie, A., Van Hove, W., Francart, H. & van den Berghe, H. (1987) A chromosomal profile of polycythemia vera. Cancer Genetics Cytogenetics, 25, 233-245.
29. Rege-Cambrin, G., Speleman, F., Kerim, S., Scaravaglio, P., Dal Cin, P., Michaux, J.L., Offner, F., Saglio, G. & van den Berghe, H. (1991) Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders. Leukemia, 5, 1059-1063.
30. Richard, S., Isola, L., Scigliano, E., Singh, H., Najfeld, V., Gilbert, H., Weinberg, R.S. & Fruchtman, S. (2002) Syngeneic stem cell transplant for spent-phase Polycythaemia vera: Eradication of myelofibrisis and restoration of normal haematopoiesis. British Journal of Haematology, 116, 1-2.
31. Silva, M., Richard, C., Benito, A., Sanz, C., Olalla, I. & Fernandez-Luna, J.L. (1998) Expression of BCL-x in erythroid precursors from patients with polycythemia vera. New England Journal of Medicine, 338, 564-571.
32. Swolin, B., Weinfeld, A. & Westin, J. (1986) Trisomy 1q in polycythemia vera and its relation to disease transition. American Journal of Hematology, 22, 155-167.
33. Swolin, B., Weinfeld, A. & Westin, A. (1988) A prospective long-term cytogenetic study in Polycythemia vera in relation to treatment and clinical course. Blood, 72, 386-395.
34. Swolin, B., Safai-Kutti, S., Anghem, E. & Kutii, J. (2001) No increased frequency of trisomies 8 and 9 by fluorescence in situ hybridization in untreated patients with essential thrombocythemia. Cancer Genetics and Cytogenetics, 126, 56-59.
35. Tefferi, A., Yoon, S.-Y. & Li, C.-Y. (2000) Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis. Blood, 96, 771-772.
36. Temerinac, S., Klippel, S., Strunck, E., Rooler, S., Lubert, M., Lange, W., Azemar, M., Menhardt, G., Schaefer, H.-E. & Pahl, H.L. (2000) Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood, 95, 2569-2576.
37. Testa, J.R., Kanofsky, J.R., Rowley, J.D., Baron, J.M. & Vardiman, J.W. (1981) Karyotypic patterns and their clinical significance in Polycythemia vera. American Journal of Hematology, 11, 29-45.
38. Weinberg, R.S. (1997) In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders. Seminars in Hematology, 34, 64-69.
39. Westin, J., Wahlsrom, J. & Swolin, B. (1976) Chromosome studies in untreated polycythaemia vera. Scandinavian Journal of Haematology, 17, 183-196.
40. Westwood, N.B., Gruszka-Westwood, A.M., Pearson, L.E., DeLord, C.F.M., Green, A.R., Huntly, B.J.P., Lakhani, A., McMullin, M.F. & Pearson, T.C. (2000) The incidences of trisomy 8, trisomy 9 and D20, S108 deletion in polycythaemia vera: An analysis of blood granulocytes using interphase fluorescence in situ hybridization. British Journal of Haematology, 110, 839-846.
41. Westwood, N.B., Gruszka-Westwood, A.M., Atkinson, S. & Pearson, T.C. (2001) Polycythemia vera: Analysis of DNA from blood granulocytes using comparative genomic hybridization. Hematologica, 86, 464-469.
42. Zech, L., Gahrton, G., Killander, D., Franzen, S. & Haglund, U. (1976) Specific chromosomal aberrations in polycythemia vera. Blood, 48, 687-696.